Gilead Sciences Completes Acquisition of MiroBio
20 Sep 2022 //
BUSINESSWIRE
Gilead Sciences to acquire OSE portfolio company for approximately $405m
16 Aug 2022 //
PHARMACEUTICAL MANUFACTURER
Gilead buys MiroBio as it takes next-gen checkpoint therapy to the clinic
05 Aug 2022 //
ENDPTS
MiroBio Raises $97M Series B Financing to Develop Checkpoint Agonists
29 Jun 2022 //
GLOBENEWSWIRE
Oxford spinout nabs almost $100M in new cash
28 Jun 2022 //
ENDPTS
MiroBio Continues Expansion of Executive Leadership Team
08 Mar 2022 //
GLOBENEWSWIRE
Novartis loses cell, gene leader, digital exec—Chutes & Ladders
24 Sep 2021 //
FIERCEBIOTECH
Novartis veteran Barth takes the helm at autoimmune biotech MiroBio
21 Sep 2021 //
FIERCEBIOTECH